Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine-A vs. Prednisolone in Autoimmune Hepatitis
NCT01170351Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2005
- Primary completion
- Dec 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclosporine in autoimmune hepatitis (AIH) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Remission at 12 months and Treatment failure at 3 months. Started Dec 2005; status: completed.
02
Drugs
cyclosporine
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT01170351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170351.